The Comparison of EQ-5D-5L Versus Disease/Treatment-Specific Measures in Pulmonary Embolism and Deep Vein Thrombosis

Ling‐Hsiang Chuang; AT Cohen; Giancarlo Agnelli; PD Gumbs; Rupert Bauersachs; Sonja Kroep; Patrick Mismetti; A. K. Gitt; Manuel Monréal; SN Willich; Ben van Hout

doi:10.1016/j.jval.2017.08.1363

Related publications

Article2019

Comparison of quality of life measurements: EQ-5D-5L versus disease/treatment-specific measures in pulmonary embolism and deep vein thrombosis

Ling‐Hsiang Chuang, Alexander T. Cohen, Giancarlo Agnelli, Pearl D Gumbs, Rupert Bauersachs, Sonja Kroep, Anselm K. Gitt, Manuel Monréal, Stefan N. Willich, Ben van Hout

Article2016

Guidance for the treatment of deep vein thrombosis and pulmonary embolism

Michael B. Streiff, Giancarlo Agnelli, Jean M. Connors, Mark Crowther, Sabine Eichinger, Renato D. Lópes, Robert D. McBane, Stephan Moll, Jack Ansell

Corrigendum2016

Erratum to: Guidance for the treatment of deep vein thrombosis and pulmonary embolism

Michael B. Streiff, Giancarlo Agnelli, Jean M. Connors, Mark Crowther, Sabine Eichinger, Renato D. Lópes, Robert D. McBane, Stephan Moll, Jack Ansell

Article2014

O3.08: Lung diseases in the elderly increase the risk of pulmonary embolism more than of deep vein thrombosis

Zeki Karasu, Mary Cushman, Frits R. Rosendaal, Astrid van Hylckama Vlieg

European Geriatric Medicine

Article2012

Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum

Kirsten van Langevelde, Linda E. Flinterman, Astrid van Hylckama Vlieg, Frits R. Rosendaal, Suzanne C. Cannegieter

Blood